Yasaman Ardeshirpour, Ph.D.
Affiliations: | 2010 | University of Connecticut, Storrs, CT, United States |
Area:
Electronics and Electrical Engineering, Biomedical Engineering, Radiology, Optics PhysicsGoogle:
"Yasaman Ardeshirpour"Parents
Sign in to add mentorQuing Zhu | grad student | 2010 | University of Connecticut | |
(Improving the light quantification of near infrared (NIR) diffused light optical tomography with ultrasound localization.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Afshari A, Keil M, Lyssikatos C, et al. (2019) Correction: Optical Imaging Technology: A Useful Tool to Identify Remission in Cushing Disease After Surgery. Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme |
Afshari A, Keil M, Lyssikatos C, et al. (2019) Optical Imaging Technology: A Useful Tool to Identify Remission in Cushing Disease After Surgery. Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme |
Ardeshirpour Y, Sackett DL, Knutson JR, et al. (2018) Using in vivo fluorescence lifetime imaging to detect HER2-positive tumors. Ejnmmi Research. 8: 26 |
Dasgeb B, Smirnov AV, Ardeshirpour Y, et al. (2014) Multiscale BerEp4 Molecular Imaging of Microtumor Phantoms: Toward Theranostics for Basal Cell Carcinoma. Molecular Imaging. 13: 7290201400016 |
Dasgeb B, Smirnov AV, Ardeshirpour Y, et al. (2014) Multiscale BerEp4 molecular imaging of microtumor phantoms: toward theranostics for basal cell carcinoma. Molecular Imaging. 13 |
Ardeshirpour Y, Chernomordik V, Hassan M, et al. (2014) In vivo fluorescence lifetime imaging for monitoring the efficacy of the cancer treatment. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 3531-9 |
Ardeshirpour Y, Hassan M, Zielinski R, et al. (2014) In vivo assessment of HER2 receptor density in HER2-positive tumors by near-infrared imaging, using repeated injections of the fluorescent probe. Technology in Cancer Research & Treatment. 13: 427-34 |
Chernomordik V, Ardeshirpour Y, Hassan M, et al. (2014) Near-Infrared Fluorescence Imaging for In Vivo Assessment of HER2 Receptor Density in HER2-positive Tumors Ieee Transactions On Biomedical Engineering |
Afshari A, Lodish M, Ardeshirpour Y, et al. (2014) Using quantitative diffuse multi spectral imaging method to assess Cushing disease treatment outcome Ieee Transactions On Biomedical Engineering |
Ardeshirpour Y, Chernomordik V, Hassan M, et al. (2014) Monitoring the efficacy of targeted therapy with in vivo fluorescence lifetime imaging Ieee Transactions On Biomedical Engineering |